Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
MolecuLight logo — i:X & DX point-of-care detection of wounds containing elevat...

MolecuLight

i:X & DX point-of-care detection of wounds containing elevated bacterial burden & digital wound measurement #moleculight

Founded 2013 Canada Toronto, Canada 53 employees Venture round Total: $31.50M Health Care, Medical Devices

General Information

Company Name MolecuLight
Founded Year 2013
Location Canada Toronto, Canada
Employees 53
Industries Health Care, Medical Devices
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with MolecuLight . To contact MolecuLight , visit moleculight.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does MolecuLight compare?

A PDF of MolecuLight and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting MolecuLight soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About MolecuLight

MolecuLight is a privately-owned medical imaging company that has developed and is commercializing its proprietary fluorescent imaging platform technology. Since its establishment in 2013, MolecuLight has made significant strides in the Health Care industry. The company's suite of commercially released devices, including the MolecuLight i:X® and DX™ fluorescence imaging systems, offer point-of-care handheld imaging devices for the global wound care market. These devices are designed for the real-time detection of wounds containing elevated bacterial burden > 10^4 CFU/g (when used with clinical signs and symptoms) and for digital wound measurement. The most recent Venture Round investment was secured on 11th August 2022, with participation from iGan Partners and BDC Capital. This capital injection exemplifies the ongoing confidence in MolecuLight's innovative technology and its potential to make a positive impact within the health care sector. As the company continues to advance its cutting-edge solutions, its commitment to transforming wound care through advanced imaging technology remains evident. #moleculight.

Taxonomy: Fluorescence Imaging, Wound Care, Point-of-care Imaging, Limb Salvage, Advanced Wound Care Therapies, Wound Healing, Digital Wound Measurement, Wound Measurement Tools, Antimicrobial Stewardship, Imaging of Bacterial Burden, Wound Cleaning, Wound Debridement, Vascular Surgery, Diabetic Foot Ulcers, Biofilm

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round Undisclosed 2
iGan Partners BDC Capital
iGan Partners, BDC Capital
11 Aug 2022
Debt Financing $10.00M 1
SWK Holdings
04 Jan 2022
Debt Financing $7.50M 1
Oxford Finance LLC
19 Aug 2019
Convertible Note $5.00M 1
LVL1 Group
LVL1 Group
01 Dec 2017
Series B $5.00M 1
LVL1 Group
LVL1 Group
01 Oct 2015
Seed Round $4.00M 1
iGan Partners
iGan Partners
30 May 2014

MolecuLight Alternatives & Competitors

View All Alternatives
MolecuLight vs
Vaporox Inc.
Vaporox Inc. United States

Revolutionizing Wound Care Through the Power of Vaporous Hyperoxia Therapy (VHT™)

Series A
18 employees
Health Care, Medical Devices
MolecuLight vs
Kerecis
Kerecis Iceland

Kerecis is pioneering the use of fish skin and fatty-acids in the cellular therapy and regenerative...

Debt Financing
517 employees
Health Care, Manufacturing
MolecuLight vs
BL Lifesciences
BL Lifesciences India

At The Heart of Critical Moments

161 employees
Biotechnology, Health Care
View all alternatives

FAQ About MolecuLight

i:X & DX point-of-care detection of wounds containing elevated bacterial burden & digital wound measurement #moleculight
MolecuLight was founded in 2013.
MolecuLight is headquartered in Toronto, Canada.
MolecuLight operates in Health Care and Medical Devices. Its work centres on Fluorescence Imaging, Wound Care, Point-of-care Imaging and Limb Salvage.
MolecuLight has approximately 53 employees.
MolecuLight has completed 6 funding rounds, raising a total of $31.50M. The latest funding stage is Venture round.
Top alternatives and competitors to MolecuLight include Vaporox Inc., Kerecis, BL Lifesciences, AOTI, Magnolia Medical Technologies. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
MolecuLight and Vaporox Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for MolecuLight , https://bouncewatch.com/company/moleculight, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes